CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells

MLA

Chiyuki Ueshima, et al. “CEACAM1 Long Isoform Has Opposite Effects on the Growth of Human Mastocytosis and Medullary Thyroid Carcinoma Cells.” Cancer Medicine, vol. 6, no. 4, Apr. 2017, pp. 845–56. EBSCOhost, https://doi.org/10.1002/cam4.1050.

APA

Chiyuki Ueshima, Tatsuki R. Kataoka, Yusuke Takei, Masahiro Hirata, Akihiko Sugimoto, Mitsuyoshi Hirokawa, Yoshimichi Okayama, Richard S. Blumberg, & Hironori Haga. (2017). CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells. Cancer Medicine, 6(4), 845–856. https://doi.org/10.1002/cam4.1050

Chicago

Chiyuki Ueshima, Tatsuki R. Kataoka, Yusuke Takei, Masahiro Hirata, Akihiko Sugimoto, Mitsuyoshi Hirokawa, Yoshimichi Okayama, Richard S. Blumberg, and Hironori Haga. 2017. “CEACAM1 Long Isoform Has Opposite Effects on the Growth of Human Mastocytosis and Medullary Thyroid Carcinoma Cells.” Cancer Medicine 6 (4): 845–56. doi:10.1002/cam4.1050.